SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/258803"
 

Search: onr:"swepub:oai:gup.ub.gu.se/258803" > Histological improv...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Borssen, A. D. (author)

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis A cohort study

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • Ovid Technologies (Wolters Kluwer Health),2017

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/258803
  • https://gup.ub.gu.se/publication/258803URI
  • https://doi.org/10.1097/md.0000000000007708DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Autoimmune hepatitis (AIH) is a chronic autoimmune liver disease that if left untreated may lead to the development of cirrhosis. Previous studies on AIH patients have suggested that fibrosis and even cirrhosis can be reversed by medical treatment. The aim of this study was to evaluate the efficacy of medical treatment for protection of developing fibrosis and cirrhosis. A total of 258 liver biopsies from 101 patients (72 women, 29 men) were analyzed by a single pathologist and classified according to the Ishak grading (inflammation) and staging (fibrosis) system. Liver histology was stratified according to the temporal changes of fibrosis stage (increased, decreased, or stable), and groups were compared. Complete or partial response to medical treatment was 94.9%. Reduction of fibrosis stage from the first to the last biopsy was seen in 63 patients (62.4%). We found an association between a reduction in the fibrosis stage and continuous glucocorticoid medication, as well as lowered scores of inflammation at last biopsy. Twenty-one patients had cirrhosis (Ishak stage 6) at least in one of the previous biopsies, but only 5 patients at the last biopsy. Histological improvement is common in AIH patients that respond to medical treatment, and a reduction or stabilization of fibrosis stage occurs in about 2/3 of such patients.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Palmqvist, R. (author)
  • Kechagias, S. (author)
  • Marschall, Hanns-Ulrich,1954Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xmarsh (author)
  • Bergquist, A. (author)
  • Rorsman, F. (author)
  • Weiland, O. (author)
  • Verbaan, H. (author)
  • Nyhlin, N. (author)
  • Nilsson, E. (author)
  • Werner, M. (author)
  • Göteborgs universitetInstitutionen för medicin, avdelningen för molekylär och klinisk medicin (creator_code:org_t)

Related titles

  • In:Medicine (United States): Ovid Technologies (Wolters Kluwer Health)96:340025-7974

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view